| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer
|
Kawahara, Akihiko
|
|
2012
|
78 |
1 |
p. 39-44
6 p.
|
artikel
|
| 2 |
An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases
|
Sandler, Alan
|
|
2012
|
78 |
1 |
p. 1-7
7 p.
|
artikel
|
| 3 |
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer
|
Clément-Duchêne, Christelle
|
|
2012
|
78 |
1 |
p. 57-62
6 p.
|
artikel
|
| 4 |
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
|
Grønberg, Bjørn H.
|
|
2012
|
78 |
1 |
p. 63-69
7 p.
|
artikel
|
| 5 |
Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium
|
Campbell, Nicholas P.
|
|
2012
|
78 |
1 |
p. 76-80
5 p.
|
artikel
|
| 6 |
Comparative study of solitary thin-walled cavity lung cancer with computed tomography and pathological findings
|
Xue, XinYing
|
|
2012
|
78 |
1 |
p. 45-50
6 p.
|
artikel
|
| 7 |
Contents
|
|
|
2012
|
78 |
1 |
p. ix-x
nvt p.
|
artikel
|
| 8 |
Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors
|
Honda, Yoshihiro
|
|
2012
|
78 |
1 |
p. 121-124
4 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2012
|
78 |
1 |
p. vii-
1 p.
|
artikel
|
| 10 |
EGFR mutations and mucoepidermoid carcinoma: Putative significance in differing populations
|
O’Neill, Iain D.
|
|
2012
|
78 |
1 |
p. 125-126
2 p.
|
artikel
|
| 11 |
Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
|
Okamura, Kyoko
|
|
2012
|
78 |
1 |
p. 100-106
7 p.
|
artikel
|
| 12 |
Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC
|
Grimminger, Peter P.
|
|
2012
|
78 |
1 |
p. 87-91
5 p.
|
artikel
|
| 13 |
Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype
|
Metro, Giulio
|
|
2012
|
78 |
1 |
p. 81-86
6 p.
|
artikel
|
| 14 |
Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response
|
Fujii, Masanori
|
|
2012
|
78 |
1 |
p. 107-111
5 p.
|
artikel
|
| 15 |
Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy
|
Fischer, Bruno
|
|
2012
|
78 |
1 |
p. 23-29
7 p.
|
artikel
|
| 16 |
Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT
|
Wang, Jingbo
|
|
2012
|
78 |
1 |
p. 51-56
6 p.
|
artikel
|
| 17 |
Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: A retrospective study of 300 patients
|
Nagy-Mignotte, Hélène
|
|
2012
|
78 |
1 |
p. 112-120
9 p.
|
artikel
|
| 18 |
Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin
|
Tiseo, Marcello
|
|
2012
|
78 |
1 |
p. 92-99
8 p.
|
artikel
|
| 19 |
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer
|
Spigel, David R.
|
|
2012
|
78 |
1 |
p. 70-75
6 p.
|
artikel
|
| 20 |
Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: A literature-based meta-analysis of 24 trials
|
Petrelli, Fausto
|
|
2012
|
78 |
1 |
p. 8-15
8 p.
|
artikel
|
| 21 |
Rising incidence of adenocarcinoma of the lung in Canada
|
Jiang, XiaoHong
|
|
2012
|
78 |
1 |
p. 16-22
7 p.
|
artikel
|
| 22 |
The association of elevated 2′,5′-oligoadenylate-dependent RNase L with lung cancer correlated with deficient enzymatic activity and decreased capacity of RNase L dimerization
|
Yin, Huijing
|
|
2012
|
78 |
1 |
p. 30-38
9 p.
|
artikel
|
Tijdschrift beschrijving